The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis
NCT ID: NCT04779164
Last Updated: 2021-03-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
126 participants
INTERVENTIONAL
2020-09-04
2020-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:The aim of this study is to determine whether type-2 diabetes itself, independent of abdominal obesity, is a risk factor for femoral cartilage, knee osteoarthritis and poor quality of life.
Design:A cross-sectional design. Settings:Training and research hospital in Turkey. Patients and Methods:Female patients was enrolled in this study and divided into two groups: according to presence or absence of diabetes. Later, both the patients with and without abdominal obesity was divided into two groups according the presence of diabetes.
Main Outcome measures:Clinical parameters were visual analog-scale, gait speed and short form-36. Knee radiographs were evaluated according to Kellgren Lawrance-Scale. And ultrasonography parameters were the measurements of distal femoral cartilage thickness.
Sample size:126
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Femoral Cartilage Thickness in Knee Osteoarthritis
NCT05456711
Blood Flow Restriction Exercises and Conservative Exercises in Knee Osteoarthritis
NCT04535596
Is Pulsed Ultrasound Treatment Effective in Knee Osteoarthritis
NCT03705039
Identification of Sarcopenia in Knee Osteoarthritis With Ultrasonography and Evaluation of Muscle Architecture Change by Ultrasonography After Isokinetic Exercise Program
NCT05019820
The Effect of Dextrose Prolotherapy on Isokinetic Power in the Treatment of Knee Osteoarthritis
NCT04958213
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with type 2 diabetes
Patients with diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
knee ultrasonography
The knees of all patients were screened with ultrasonography device for the measurement of femoral cartilage thicknesses.
Patients without type 2 diabetes
Patients without diabetes mellitus was evaluated in terms of pain scores and ultrasonographic femoral cartilage thickness and retrospective radiographic knee osteoarthritis scores.
knee ultrasonography
The knees of all patients were screened with ultrasonography device for the measurement of femoral cartilage thicknesses.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
knee ultrasonography
The knees of all patients were screened with ultrasonography device for the measurement of femoral cartilage thicknesses.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged between 40 and 70.
Exclusion Criteria
* rheumatoid arthritis
* cardiac diseases (except type 2 diabetes mellitus and hypertension)
* knee surgery
* trauma
* bone mass or cancer
* inflammatory arthritis
* impaired cognitive status
* immobilized patients
* type 1 diabetes mellitus
40 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eskisehir City Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fulya Bakılan
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fulya Bakılan
Role: PRINCIPAL_INVESTIGATOR
Eskisehir City Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eskişehir City Hospital
Eskişehir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EskCityHosp
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.